Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasms 5Ovarian Neoplasms 3Lung Neoplasms 3Breast Neoplasms 3Prostatic Neoplasms 2Lymphoma 2Head and Neck Neoplasms 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Brain Neoplasms 2Adenocarcinoma 2Urticaria 1Tuberous Sclerosis 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Severe Combined Immunodeficiency 1Salivary Gland Neoplasms 1Renal Insufficiency, Chronic 1Rectal Neoplasms 1Pancreatitis, Chronic 1Pancreatitis 1Pancreatic Cyst 1Non-alcoholic Fatty Liver Disease 1Neuroendocrine Tumors 1Neuroblastoma 1Nephritis 1Neoplasm Metastasis 1Multiple Sclerosis 1Mucopolysaccharidosis I 1Melanoma 1

Interventions

Blood Specimen Collection 5Therapeutics 2Surveys and Questionnaires 2Cetuximab 2temsirolimus 1Tumor Burden 1Spectrum Analysis, Raman 1Risedronic Acid 1Raloxifene Hydrochloride 1Radiotherapy, Intensity-Modulated 1Radiomics 1Radiation, Ionizing 1Quality of Life 1Phlebotomy 1Neck Dissection 1Mohs Surgery 1Microscopy, Confocal 1Interviews as Topic 1Immunotherapy 1Ibandronic Acid 1Histocompatibility Testing 1Etidronic Acid 1Esophagectomy 1Dermoscopy 1Carboxylesterase 1Alendronate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Carcinoma, Squamous Cell × Phlebotomy × Clear all
NCT00507702 2019-04-18

Identification of Key Blood Molecular Markers for Immunotherapy

Stanford University

Terminated
191 enrolled
Tumor-Agnostic

Adenocarcinoma, Carcinoma, Squamous Cell, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡